ABI3 and cancer: After applying CNV levels for patient grouping by GSCA, our analysis revealed that high ABI3 CNV group patients had lower overall survival rates in several cancer types, including ACC, CHOL, LGG, LAML, SARC, UCEC, and UCS, as shown in Figure 5D.